Cargando…

Correction to: NP213 (Novexatin(®)): A unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10446138/ https://www.ncbi.nlm.nih.gov/pubmed/37611076 http://dx.doi.org/10.1093/mmy/myad088

Ejemplares similares

NP213 (Novexatin(®)): A unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile
por: Mercer, Derry K, et al.
Publicado: (2020)

Improved Methods for Assessing Therapeutic Potential of Antifungal Agents against Dermatophytes and Their Application in the Development of NP213, a Novel Onychomycosis Therapy Candidate
por: Mercer, Derry K., et al.
Publicado: (2019)

Correction: Prospective, comparative evaluation of a deep neural network and dermoscopy in the diagnosis of onychomycosis
por: Kim, Young Jae, et al.
Publicado: (2020)

An Unusual Presentation of Candidal Onychomycosis: A Case Report
por: Aljehani, Fawaz H, et al.
Publicado: (2023)

Correction: The Transcriptional Regulator Np20 Is the Zinc Uptake Regulator in Pseudomonas aeruginosa
por: Ellison, Matthew L., et al.
Publicado: (2013)

Efficacy and Safety of 1% Clotrimazole Cream Occlusion with the Mechanical Reduction as an Adjuvant Therapy for the Treatment of Onychomycosis
por: Wimoolchart, Saranjit, et al.
Publicado: (2018)

Correction: Disease and patient characteristics in NP-C patients: findings from an international disease registry
por: Patterson, Marc C, et al.
Publicado: (2013)

Correction: E47 upregulates ΔNp63α to promote growth of squamous cell carcinoma
por: Xu, Jing, et al.
Publicado: (2022)

Correction: Ethnic variation and the relevance of homozygous RNF 213 p.R4810.K variant in the phenotype of Indian Moya moya disease
Publicado: (2021)

Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type
por: Schifanella, Luca, et al.
Publicado: (2020)

Correction: Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa
por: Brookes, Roger H., et al.
Publicado: (2011)

Safety and efficacy of tinea pedis and onychomycosis treatment in people with diabetes: a systematic review
por: Matricciani, Lisa, et al.
Publicado: (2011)

Correction: Defining unique clinical hallmarks for immune checkpoint inhibitor-based therapies
Publicado: (2022)

Laser Therapy for Onychomycosis: Fact or Fiction?
por: Liddell, Lucette Teel, et al.
Publicado: (2015)

Correction: ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis
por: Park, Sunyoung, et al.
Publicado: (2019)

Correction to: The efficacy and safety profile of 2-weekly dosing of bevacizumab-containing chemotherapy for platinum-resistant recurrent ovarian cancer
por: Sekine, Masayuki, et al.
Publicado: (2021)

Preliminary Evidence of the Efficacy of Nitric Acid Treatment in Onychomycosis
por: Marcos-Tejedor, Félix, et al.
Publicado: (2021)

Correction to: Cross-sectional associations among P3NP, HtrA, Hsp70, Apelin and sarcopenia in Taiwanese population
por: Chen, Yuan-Yuei, et al.
Publicado: (2022)

Recent advances in therapies for onychomycosis and its management
por: Gupta, Aditya K., et al.
Publicado: (2019)

Comprehensive N-Glycan Profiling of Cetuximab Biosimilar Candidate by NP-HPLC and MALDI-MS
por: Liu, Sheng, et al.
Publicado: (2017)

Combination Therapy Should Be Reserved as Second-Line Treatment of Onychomycosis: A Systematic Review of Onychomycosis Clinical Trials
por: Falotico, Julianne M., et al.
Publicado: (2022)

Correction: Zhou, P., et al. Notoginsenoside R1 Ameliorates Diabetic Retinopathy through PINK1-Dependent Activation of Mitophagy. Cells, 2019, 8, 213
por: Zhou, Ping, et al.
Publicado: (2020)

Correction: DeltaNp63alpha-Mediated Induction of Epidermal Growth Factor Receptor Promotes Pancreatic Cancer Cell Growth and Chemoresistance
por: Danilov, Alexey V., et al.
Publicado: (2018)

Correction to: ΔNp63α promotes Bortezomib resistance via the CYGB–ROS axis in head and neck squamous cell carcinoma
por: Zhou, Peng, et al.
Publicado: (2022)

Correction: Hung et al. Anti-Inflammatory Fibronectin-AgNP for Regulation of Biological Performance and Endothelial Differentiation Ability of Mesenchymal Stem Cells. Int. J. Mol. Sci. 2021, 22, 9262
por: Hung, Huey-Shan, et al.
Publicado: (2022)

Correction to: The uniqueness of subjective ageing: convergent and discriminant validity
por: Spuling, Svenja M., et al.
Publicado: (2021)

Translation elongation factor 1-alpha gene as a marker for diagnosing of candidal onychomycosis
por: Pakshir, Keyvan, et al.
Publicado: (2020)

Treatment of Onychomycosis: An Update
por: Shirwaikar, A. A., et al.
Publicado: (2008)

Efinaconazole in the treatment of onychomycosis
por: Lipner, Shari R, et al.
Publicado: (2015)

Nail clipping in onychomycosis
por: Bertanha, Laura, et al.
Publicado: (2016)

The Dermatologist’s Approach to Onychomycosis
por: Queller, Jenna N., et al.
Publicado: (2015)

Onychomycosis: A Review
por: Piraccini, Bianca Maria, et al.
Publicado: (2015)

Propolis for the Treatment of Onychomycosis
por: Veiga, Flavia Franco, et al.
Publicado: (2018)

Onychomycosis: An Updated Review
por: Leung, Alexander K.C., et al.
Publicado: (2020)

Onychomycosis: Old and New
por: Maskan Bermudez, Narges, et al.
Publicado: (2023)

Author Correction: Vascular tortuosity of the internal carotid artery is related to the RNF213 c.14429G > A variant in moyamoya disease
por: An, Sungjae, et al.
Publicado: (2020)

Trichophyton erinacei Onychomycosis: The First to Evidence a Proximal Subungual Onychomycosis Pattern
por: Phaitoonwattanakij, Sutasinee, et al.
Publicado: (2019)

Candidal Onychomycosis: Clinicoepidemiological Profile, Prevailing Strains, and Antifungal Susceptibility Pattern–A Study from a Tertiary Care Hospital
por: Rather, Shagufta, et al.
Publicado: (2021)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01(E) in 5 to 17 Month Old Kenyan and Tanzanian Children
por: Lusingu, John, et al.
Publicado: (2010)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01(E) in 5 to 17 Month Old Kenyan and Tanzanian Children
por: Lusingu, John, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_uts45oefj5lp5d0cvr551rdc71